7 results
PRE 14A
GLUE
Monte Rosa Therapeutics Inc
12 Apr 23
Preliminary proxy
4:07pm
responsibility is to monitor and oversee these processes.
In connection with these responsibilities, the audit committee reviewed and discussed with management
DEF 14A
GLUE
Monte Rosa Therapeutics Inc
27 Apr 22
Definitive proxy
4:10pm
. The audit committee’s responsibility is to monitor and oversee these processes.
In connection with these responsibilities, the audit committee reviewed
S-1
EX-10.18
03h9euar07ij4i4
4 Jun 21
IPO registration
9:07am
DRS/A
EX-10.17
sgqu9
30 Apr 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next